Commission Implementing Regulation (EU) No 828/2014 of 30 July 2014 on the requirements for the provision of information to consumers on the absence or reduced presence of gluten in food (Text with EEA relevance)
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/regulation/2014/828@2014-07-30/en
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food information to consumers, and in particular Article 36(3)(d) thereof,
Whereas:
(1) People with coeliac disease suffer from a permanent intolerance to gluten. Wheat (i.e. all Triticum species, such as durum wheat, spelt, and khorasan wheat), rye and barley have been identified as grains that are scientifically reported to contain gluten. The gluten present in those grains can cause adverse health effects to people intolerant to gluten and therefore its consumption should be avoided by such people.
(2) Information on the absence or reduced presence of gluten in food should help people intolerant to gluten to identify and choose a varied diet when eating inside or outside the home.
(3) Commission Regulation (EC) No 41/2009 sets out harmonised rules on the information provided to consumers on the absence (gluten-free) or reduced presence of gluten (very low gluten) in food. The rules of that Regulation are based on scientific data and guarantee that consumers are not misled or confused by information provided on a divergent basis on the absence or reduced presence of gluten in food.
(4) In the context of the revision of the legislation on foodstuffs intended for particular nutritional uses Regulation (EU) No 609/2013 of the European Parliament and of the Council repeals Regulation (EC) No 41/2009 from 20 July 2016. It should be ensured that, after that date, the provision of information on the absence or reduced presence of gluten in food continues to be based on the relevant scientific data and is not provided on a divergent basis which could mislead or confuse the consumers, in accordance with the requirements laid down in Article 36(2) of Regulation (EU) No 1169/2011. It is therefore necessary that uniform conditions for the application of these requirements to food information provided by food business operators on the absence or reduced presence of gluten in food are maintained in the Union and these conditions should be based on Regulation (EC) No 41/2009.
(5) Certain foods have been specially produced, prepared and/or processed to reduce the gluten content of one or more gluten-containing ingredients or to substitute the gluten-containing ingredients with other ingredients naturally free of gluten. Other foods are made exclusively from ingredients that are naturally free of gluten.
(6) The removal of gluten from gluten-containing grains presents considerable technical difficulties and economic constraints and therefore the manufacture of totally gluten-free food when using such grains is difficult. Consequently, many foods especially processed to reduce the gluten content of one or more gluten-containing ingredients on the market may contain low residual amounts of gluten.
(7) Most people with intolerance to gluten can include oats in their diet without adverse effect on their health. This is an issue of ongoing study and investigation by the scientific community. However, a major concern is the contamination of oats with wheat, rye or barley that can occur during grain harvesting, transport, storage and processing. Therefore, the risk of gluten contamination in products containing oats should be taken into consideration with regard to the relevant information provided on those food products by food business operators.
(8) Different people with intolerance to gluten may tolerate variable small amounts of gluten within a restricted range. In order to enable individuals to find on the market a variety of foodstuffs appropriate for their needs and for their level of sensitivity, a choice of products should be possible with different low levels of gluten within such a restricted range. It is important, however, that the different products are properly labelled in order to ensure their correct use by people intolerant to gluten with the support of information campaigns fostered in the Member States.
(9) It should be possible for a food which is specially produced, prepared and/or processed to reduce the gluten content of one or more gluten-containing ingredients or to substitute the gluten-containing ingredients with other ingredients naturally free of gluten to bear terms indicating either the absence (gluten-free) or reduced presence (very low gluten) of gluten in accordance with the provisions laid down in this Regulation. It should also be possible for this food to bear a statement informing consumers that it is specifically formulated for people intolerant to gluten.
(10) It should also be possible for a food containing ingredients naturally free of gluten to bear terms indicating the absence of gluten, in accordance with the provisions laid down in this Regulation and provided that the general conditions on fair information practices set out in Regulation (EU) No 1169/2011 are complied with. In particular, food information should not be misleading by suggesting that the food possesses special characteristics when in fact all similar foods possess such characteristics.
(11) Commission Directive 2006/141/EC prohibits the use of ingredients containing gluten in the manufacture of infant formulae and follow-on formulae. Therefore, the use of the statements very low gluten or gluten-free when providing information on such products should be prohibited given that pursuant to the present Regulation, these statements are used for indicating respectively a content of gluten not exceeding 100 mg/kg and 20 mg/kg.
(12) The Codex Standard for Foods for Special Dietary Use for Persons Intolerant to Gluten should be taken appropriately into consideration for the purposes of this Regulation.
(13) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS REGULATION:
Article 1 Scope and subject matter
This Regulation applies to the provision of information to consumers on the absence or reduced presence of gluten in food.
Article 2 Definitions
For the purposes of this Regulation, the following definitions shall apply:
(a) gluten means a protein fraction from wheat, rye, barley, oats or their crossbred varieties and derivatives thereof, to which some persons are intolerant and which is insoluble in water and 0,5 M sodium chloride solution;
(b) wheat means any Triticum species.
Article 3 Information to consumers
1. Where statements are used to provide information to consumers on the absence or reduced presence of gluten in food, such information shall be given only through the statements and in accordance with the conditions set out in the Annex.
2. The food information referred to in paragraph 1 may be accompanied by the statements suitable for people intolerant to gluten or suitable for coeliacs.
3. The food information referred to in paragraph 1 may be accompanied by the statements specifically formulated for people intolerant to gluten or specifically formulated for coeliacs if the food is specially produced, prepared and/or processed to:
(a) reduce the gluten content of one or more gluten-containing ingredients; or
(b) substitute the gluten-containing ingredients with other ingredients naturally free of gluten.
Article 4 Infant formulae and follow-on formulae
The provision of food information on the absence or reduced presence of gluten in infant formulae and follow-on formulae as defined in Directive 2006/141/EC shall be prohibited.
Article 5 Entry into force and application
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. It shall apply from 20 July 2016.
This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 30 July 2014. For the Commission The President José Manuel Barroso
ANNEX
ANNEX Statements on the absence or reduced presence of gluten in food that are allowed to be made and conditions thereof A.
General requirements
GLUTEN-FREE
The statement gluten-free may only be made where the food as sold to the final consumer contains no more than 20 mg/kg of gluten.
VERY LOW GLUTEN
The statement very low gluten may only be made where the food, consisting of or containing one or more ingredients made from wheat, rye, barley, oats or their crossbred varieties which have been specially processed to reduce the gluten content, contains no more than 100 mg/kg of gluten in the food as sold to the final consumer.
B.
Additional requirements for food containing oats Oats contained in a food presented as gluten-free or very low gluten must have been specially produced, prepared and/or processed in a way to avoid contamination by wheat, rye, barley, or their crossbred varieties and the gluten content of such oats cannot exceed 20 mg/kg.
Versions
Cited by
- Commission Implementing Regulation (EU) 2018/1032 of 20 July 2018 authorising the extension of use of oil from the micro algae Schizochytrium sp. as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance) Regulation · Grade B
In the Annex to Implementing Regulation (EU) 2017/2470, the entry for Schizochytrium sp. (T18) oil in Table 1 (Authorised novel foods) is replaced by the following: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Schizochytrium sp. (T18) oil Specified food category Maximum levels The designation of the novel food on the labelling of the foodstuffs containing it shall be Oil from the microalgae Schizochytrium sp. Dairy products except milk-based drinks 200 mg/100 g or for cheese products 600 mg/100 g Dairy ana
- Commission Implementing Regulation (EU) 2024/2102 of 30 July 2024 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food 2'-Fucosyllactose and as regards the specifications of the novel food 2'-Fucosyllactose produced with a derivative strain of Escherichia coli BL-21 (Text with EEA relevance) Regulation · Grade B
in Table 1 (Authorised novel foods), the entry for 2'-Fucosyllactose is replaced by the following: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements 2′-Fucosyllactose Specified food category Maximum levels Unflavoured pasteurised and sterilised (including UHT) milk-based products 1,2 g/l Unflavoured fermented milk-based products 1,2 g/l for beverages 19,2 g/kg for products other than beverages Flavoured fermented milk-based products including heat-treated products 1,2 g/l for beverages 19,2 g/kg for products ot
- Commission Implementing Decision (EU) 2016/376 of 11 March 2016 authorising the placing on the market of 2′-O-fucosyllactose as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2016) 1423) (Only the Danish text is authentic) Decision · Grade B
Commission Directive 96/8/EC lays down requirements on foods intended for use in energy-restricted diets for weight reduction. Commission Directive 1999/21/EC lays down requirements for dietary foods for special medical purposes. Directive 2002/46/EC of the European Parliament and of the Council lays down requirements on food supplements. Commission Directive 2006/125/EC lays down requirements for processed cereal-based foods and baby foods for infants and young children. Commission Directive 2006/141/EC lays down requirements for infant formulae and follow-on formulae. Regulation (EC) No 1925
- Commission Implementing Decision (EU) 2016/376 of 11 March 2016 authorising the placing on the market of 2′-O-fucosyllactose as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2016) 1423) (Only the Danish text is authentic) Decision · Grade B
2′-O-Fucosyllactose as specified in Annex I may be placed on the market in the Union as a novel food ingredient for the uses defined and at the maximum levels established in Annex II without prejudice to the specific provisions of Directives 96/8/EC, 1999/21/EC, 2002/46/EC, 2006/125/EC, 2006/141/EC and Regulations (EC) No 1925/2006, (EC) No 41/2009 and Implementing Regulation (EU) No 828/2014
- Commission Implementing Regulation (EU) 2025/1549 of 30 July 2025 correcting Implementing Regulations (EU) 2023/2210 and (EU) 2022/1365 as regards the conditions of use of the novel foods 3-Fucosyllactose produced by a derivative strain of Escherichia coli K-12 DH1 and Schizochytrium sp. oil rich in DHA and EPA (Text with EEA relevance) Regulation · Grade B
In Annex to Implementing Regulation (EU) 2022/1365, the table is replaced by the following: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Data Protection Schizochytrium sp. oil rich in DHA and EPA Specified food category Maximum levels of DHA and EPA combined The designation of the novel food on the labelling of the foodstuffs containing it shall be DHA and EPA-rich oil from the microalgae Schizochytrium sp. Food supplements as defined in Directive 2002/46/EC for the adult population excluding pregnant and
- Commission Implementing Regulation (EU) 2023/950 of 12 May 2023 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food 2’-Fucosyllactose (Text with EEA relevance) Regulation · Grade B
In Table 1 (Authorised novel foods) of the Annex to Implementing Regulation (EU) 2017/2470, the entry for 2’-Fucosyllactose is replaced by the following: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements 2’-Fucosyllactose Specified food category Maximum levels The designation of the novel food on the labelling of the foodstuffs containing it shall be 2′-fucosyllactose. The labelling of food supplements containing 2′-fucosyllactose shall bear a statement that the supplements should not be used if other foods wit
- Commission Implementing Regulation (EU) 2020/24 of 13 January 2020 authorising an extension of use of chia seeds (Salvia hispanica) as a novel food and the change of the conditions of use and the specific labelling requirements of chia seeds (Salvia hispanica) under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance) Regulation · Grade B
In that opinion, the Authority considered that additional information is needed from applicants and/or from the public domain, to address the potential for acrylamide formation when foods containing chia seeds (Salvia hispanica) undergo heat treatment at or above 120 °C. In accordance with Article 11(4) of Regulation (EU) 2015/2283 the Authority has requested additional information from the relevant applicant relating to potential formation of process contaminants which may be formed during processing and production of a food (at the level of the manufacturer) and/or when a food with added chi
- Commission Implementing Regulation (EU) 2022/1365 of 4 August 2022 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food Schizochytrium sp. oil rich in DHA and EPA (Text with EEA relevance) Regulation · Grade B
In Table 1 (Authorised novel foods) of the Annex to Implementing Regulation (EU) 2017/2470, the entry for Schizochytrium sp. oil rich in DHA and EPA is replaced by the following: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Data protection Schizochytrium sp. oil rich in DHA and EPA Specified food category Maximum levels of DHA and EPA combined The designation of the novel food on the labelling of the foodstuffs containing it shall be DHA and EPA-rich oil from the microalgae Schizochytrium sp. Food suppleme
- Commission Implementing Regulation (EU) 2018/1023 of 23 July 2018 correcting Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods (Text with EEA relevance) Regulation · Grade B
Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements N-Acetyl-D-neuraminic acid Specified food category Maximum levels The designation of the novel food on the labelling of the foodstuffs containing it shall be N-acetyl-D-neuraminic acid Food supplements containing N-acetyl-D-neuraminic acid shall bear a statement that the food supplement should not be given to infants, young children and children under 10 years of age where they consume breast milk or other foods with added N-acetyl-D-neuraminic acid within the s
- Commission Implementing Regulation (EU) 2020/1559 of 26 October 2020 amending Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods (Text with EEA relevance) Regulation · Grade B
the entry for Schizochytrium sp. (T18) oil is replaced by the following: Schizochytrium sp. (T18) oil Specified food category Maximum levels The designation of the novel food on the labelling of the foodstuffs containing it shall be Oil from the microalgae Schizochytrium sp.. Dairy products except milk-based drinks 200 mg/100 g or for cheese products 600 mg/100 g Dairy analogues except drinks 200 mg/100 g or for analogues to cheese products 600 mg/100 g Spreadable fats and dressings 600 mg/100 g Breakfast cereals 500 mg/100 g Food supplements as defined in Directive 2002/46/EC 250 mg DHA/day f
- Commission Implementing Regulation (EU) 2025/2245 of 7 November 2025 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food Schizochytrium sp. (ATCC PTA-9695) oil (Text with EEA relevance) Regulation · Grade B
In Table 1 (Authorised novel foods) of the Annex to Implementing Regulation (EU) 2017/2470, the entry for Schizochytrium sp. (ATCC PTA-9695) oil is replaced by the following: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Data protection Schizochytrium sp. (ATCC PTA-9695) oil Specified food category Maximum levels of DHA Dairy products except milk-based drinks 200 mg/100 g or for cheese products 600 mg/100 g Dairy analogues except drinks 200 mg/100 g or for analogues to cheese products 600 mg/100 g Spreadabl
- Commission Implementing Regulation (EU) 2026/386 of 20 February 2026 authorising the placing on the market of defatted rapeseed powder as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance) Regulation · Grade B
in Table 1 (Authorised novel foods), the following entry is inserted in alphabetical order: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Data protection Defatted rapeseed powder Specified food category Maximum levels The designation of the novel food on the labelling of the foodstuffs containing it shall be defatted rapeseed powder. The labelling of food supplements containing defatted rapeseed powder shall bear a statement Any foodstuff containing defatted rapeseed powder from Brassica rapa L. and Brassic
- Commission Implementing Decision (EU) 2016/375 of 11 March 2016 authorising the placing on the market of lacto-N-neotetraose as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2016) 1419) (Only the Danish text is authentic) Decision · Grade B
Commission Directive 96/8/EC lays down requirements on foods intended for use in energy-restricted diets for weight reduction. Commission Directive 1999/21/EC lays down requirements for dietary foods for special medical purposes. Directive 2002/46/EC of the European Parliament and of the Council lays down requirements on food supplements. Commission Directive 2006/125/EC lays down requirements for processed cereal-based foods and baby foods for infants and young children. Commission Directive 2006/141/EC lays down requirements for infant formulae and follow-on formulae. Regulation (EC) No 1925
- Commission Implementing Decision (EU) 2016/375 of 11 March 2016 authorising the placing on the market of lacto-N-neotetraose as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2016) 1419) (Only the Danish text is authentic) Decision · Grade B
Lacto-N-neotetraose as specified in Annex I may be placed on the market in the Union as a novel food ingredient for the uses defined and at the maximum levels established in Annex II without prejudice to the specific provisions of Directives 96/8/EC, 1999/21/EC, 2002/46/EC, 2006/125/EC, 2006/141/EC and Regulations (EC) No 1925/2006, (EC) No 41/2009 and Implementing Regulation (EU) No 828/2014.
- Commission Implementing Decision (EU) 2017/2375 of 15 December 2017 authorising the placing on the market of N-acetyl-D-neuraminic acid as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 8431) (Only the English text is authentic) Decision · Grade B
Food category Maximum level Infant and follow-on formulae as defined by Regulation (EU) No 609/2013 0,05 g/L of reconstituted formula Processed cereal-based foods and baby foods for infants and young children as defined by Regulation (EU) No 609/2013 0,05 g/kg for solid foods Foods for special medical purposes for infants and young children as defined by Regulation (EU) No 609/2013 In accordance with the particular nutritional requirements of the infants and young children for whom the products are intended but in any case not higher than the maximum levels specified for the category mentioned
- Commission Implementing Regulation (EU) 2019/109 of 24 January 2019 authorising an extension of use of Schizochytrium sp. oil as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance) Regulation · Grade B
The entry for Schizochytrium sp. oil in Table 1 (Authorised novel foods) of the Annex to Implementing Regulation (EU) 2017/2470 is replaced by the following: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Schizochytrium sp. oil Specified food category Maximum levels of DHA The designation of the novel food on the labelling of the foodstuffs containing it shall be Oil from the microalgae Schizochytrium sp. Dairy products except milk-based drinks 200 mg/100 g or for cheese products 600 mg/100 g Dairy analogues
- Commission Implementing Regulation (EU) 2021/120 of 2 February 2021 authorising the placing on the market of partially defatted rapeseed powder from Brassica rapa L. and Brassica napus L. as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance) Regulation · Grade B
in Table 1 (Authorised novel foods), the following entry is inserted in alphabetical order: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Partially defatted rapeseed powder from Brassica rapa L. and Brassica napus L. Specified food category Maximum levels The designation of the novel food on the labelling of the foodstuffs containing it shall be Partially defatted Rapeseed powder. Any foodstuff containing Partially defatted Rapeseed powder from Brassica rapa L. and Brassica napus L.’ shall bear a statement
- Commission Implementing Regulation (EU) 2019/387 of 11 March 2019 authorising an extension of use of Schizochytrium sp. (ATCC PTA-9695) oil as a novel food and the change of the designation and of the specific labelling requirement of Schizochytrium sp. (ATCC PTA-9695) oil under Regulation (EU) 2015/2283 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance) Regulation · Grade B
The entry for Schizochytrium sp. (ATCC PTA-9695) oil in Table 1 (Authorised novel foods) is replaced by the following: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Schizochytrium sp. (ATCC PTA-9695) oil Specified food category Maximum levels of DHA The designation of the novel food on the labelling of the foodstuffs containing it shall be Oil from the microalgae Schizochytrium sp. Dairy products except milk-based drinks 200 mg/100 g or for cheese products 600 mg/100 g Dairy analogues except drinks 200 mg/1
- Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods (Text with EEA relevance) Regulation · Grade B
Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements N-Acetyl-D-neuraminic acid Specified food category Maximum levels The designation of the novel food on the labelling of the foodstuffs containing it shall be N-acetyl-D-neuraminic acid Food supplements containing N-acetyl-D-neuraminic acid shall bear a statement that the food supplement should not be given to infants, young children and children under 10 years of age where they consume breast milk or other foods with added N-acetyl-D-neuraminic acid within the s
- Commission Implementing Regulation (EU) 2023/961 of 12 May 2023 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food Lacto-N-neotetraose (Text with EEA relevance) Regulation · Grade B
In Table 1 (Authorised novel foods) of the Annex to Implementing Regulation (EU) 2017/2470, the entry for lacto-N-neotetraose is replaced by the following: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Lacto-N-neotetraose Specified food category Maximum levels Unflavoured pasteurised and sterilised (including UHT) milk-based products 0,6 g/l Unflavoured fermented milk-based products 0,6 g/l for beverages 9,6 g/kg for products other than beverages Flavoured fermented milk-based products including heat-treate